Johnson & Johnson reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Johnson & Johnson using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-01-21 | $2.46 | $2.47 | -0.40 % |
| Q3 | 2025-10-14 | $2.80 | $2.76 | 1.45 % |
| Q2 | 2025-07-16 | $2.77 | $2.67 | 3.75 % |
| Q1 | 2025-04-15 | $2.77 | $2.60 | 6.54 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-01-21 | $24.56B | $24.15B | 1.71 % |
| Q3 | 2025-10-14 | $23.99B | $23.75B | 1.03 % |
| Q2 | 2025-07-16 | $23.74B | $22.83B | 3.98 % |
| Q1 | 2025-04-15 | $21.89B | $21.57B | 1.50 % |
Johnson & Johnson (JNJ) is scheduled to report earnings on April 14, 2026. The last reported earnings were for reported on January 21, 2026 for Q4.
The Actual EPS was $2.46, which missed the estimate of $2.47.
The Actual Revenue was $24.6B, which beat the estimate of $24.2B.
Browse earnings estimates, EPS, and revenue on all stocks.